Defining the correlation between immune-checkpoint inhibitors-related adverse events and survival outcomes: A systematic review and meta-analysis

被引：0
|
作者：
Abdihamid, O. [1 ]
机构：
[1] Cent South Univ, CSU, Xiangya Sch Med, Oncol Dept, New Campus, Changsha, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
80P
引用
收藏
页码：S1406 / S1407
页数：2
相关论文
共 50 条
  • [31] Overweight and obesity as biomarkers for survival outcomes and immune related adverse events undergoing immunotherapy - a systematic review and meta-analysis
    Trinkner, P.
    Guenther, S.
    von Bergwelt, M.
    dos Santos, Cordas D.
    Theurich, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 227 - 227
  • [32] Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis
    Tian, Jin-Cheng
    Liu, Hui
    Yan, Lun-Jie
    Ding, Zi-Niu
    Han, Cheng-Long
    Tian, Bao-Wen
    Tan, Si-Yu
    Dong, Zhao-Ru
    Wang, Dong-Xu
    Xue, Jun-Shuai
    Mao, Xin-Cheng
    Yan, Yu-Chuan
    Li, Tao
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2115 - 2129
  • [33] OVERWEIGHT AND OBESITY AS BIOMARKERS FOR SURVIVAL OUTCOMES AND IMMUNE RELATED ADVERSE EVENTS UNDERGOING IMMUNOTHERAPY - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Trinkner, P.
    Guenther, S.
    von Bergwelt, M.
    dos Santos, D. Cordas
    Theurich, S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A5 - A6
  • [34] Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis
    Jin-Cheng Tian
    Hui Liu
    Lun-Jie Yan
    Zi-Niu Ding
    Cheng-Long Han
    Bao-Wen Tian
    Si-Yu Tan
    Zhao-Ru Dong
    Dong-Xu Wang
    Jun-Shuai Xue
    Xin-Cheng Mao
    Yu-Chuan Yan
    Tao Li
    Clinical and Experimental Medicine, 2023, 23 : 2115 - 2129
  • [35] Management and Outcomes of Hematological Immune-related Adverse Events: Systematic Review and Meta-analysis
    Wilson, Nathaniel R.
    Lockhart, Jonathan R.
    Garcia-Perdomo, Herney A.
    Oo, Thein H.
    Rojas-Hernandez, Cristhiam M.
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (01) : 13 - 24
  • [36] Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis.
    Grizzi, Giulia
    Petrelli, Fausto
    Ghidini, Michele
    Ghidini, Antonio
    Ratti, Margherita
    Panni, Stefano
    Cabiddu, Mary
    Ghilardi, Mara
    Borgonovo, Karen
    Parati, Maria Chiara
    Barni, Sandro
    Tomasello, Gianluca
    Passalacqua, Rodolfo
    Berruti, Alfredo
    Brighenti, Matteo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Immune-checkpoint inhibitors in previously treated patients with urothelial carcinoma: A systematic review and meta-analysis
    De Luca, E.
    Di Nunno, V.
    Buttigliero, C.
    Tucci, M.
    Vignani, F.
    Zichi, C.
    Ardizzoni, A.
    Massari, F.
    Di Maio, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [38] Blood cell counts can predict adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis
    Zhou, Juyue
    Du, Zhonghai
    Fu, Jie
    Yi, Xiuxiu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [39] Pancreatic adverse events of immune checkpoint inhibitors therapy for solid cancer patients: a systematic review and meta-analysis
    Zhao, Zhe
    Zhang, Weike
    Pang, Longbin
    Zeng, Liangjie
    Liu, Surui
    Liu, Jie
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis
    Ohashi, Takuma
    Takase-Minegishi, Kaoru
    Maeda, Ayaka
    Hamada, Naoki
    Yoshimi, Ryusuke
    Kirino, Yohei
    Teranaka, Hiroshi
    Kunimoto, Hiroyoshi
    Hagihara, Maki
    Matsumoto, Kenji
    Namkoong, Ho
    Horita, Nobuyuki
    Nakajima, Hideaki
    JOURNAL OF HEMATOLOGY, 2023, 12 (02) : 66 - 74
12345